Stockreport

INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025

INmune Bio Inc. - Common stock  (INMB) 
PDF Boca Raton, FL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces that David Mos [Read more]